Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 43

Results For "EPL"

565 News Found

TPVI offers a ray of hope for children with Pulmonic Valve disease
Hospitals | January 18, 2022

TPVI offers a ray of hope for children with Pulmonic Valve disease

Extending nonsurgical treatment options for Failing Pulmonic Valve in patients with congenital heart disease using Transcatheter Pulmonary Valve


Evonik to build production plant for rhamnolipids in Slovakia
Biotech | January 14, 2022

Evonik to build production plant for rhamnolipids in Slovakia

The new plant at Slovenská ?up?a site in Slovakia is scheduled to come on stream in two years


Pfizer and Beam enter research collaboration for In Vivo base editing programme
Biotech | January 11, 2022

Pfizer and Beam enter research collaboration for In Vivo base editing programme

Four-year research collaboration combines Pfizer’s deep experience in global drug development, including programs utilizing messenger RNA (mRNA), lipid nanoparticles (LNP), and gene therapy, with Beam’s leadership in base editing and mRNA/LNP delivery technologies


Takeda to acquire Adaptate Biotherapeutics
Biotech | January 11, 2022

Takeda to acquire Adaptate Biotherapeutics

Acquisition adds Adaptate’s novel antibody-based ?? T-cell engager platform to Takeda’s Immuno-oncology portfolio built around the Innate Immune System


Roche introduces cobas infinity edge
Medical Device | January 11, 2022

Roche introduces cobas infinity edge

Cobas infinity edge is designed as an open platform, allowing healthcare professionals to easily access and adopt third-party innovators’ new digital tools and medically-relevant applications via the Roche digital marketplace


Algorithmic Biologics receives seed funding from Axilor Lab
Startup | January 11, 2022

Algorithmic Biologics receives seed funding from Axilor Lab

The company’s platform technology works like a compression algorithm for molecular testing and has applications in healthcare, pharmaceuticals, agriculture, animal husbandry, food safety, synthetic biology, and molecular biology research


Indica Labs receive CE Mark for its HALO AP
Medical Device | January 10, 2022

Indica Labs receive CE Mark for its HALO AP

The HALO AP platform was developed by Indica Labs to address the specific needs of anatomic pathology labs by supporting a wide range of tissue-based workflows, including primary diagnosis, secondary consults, tumour boards, clinical trials, synoptic reporting, quantitative analytics, and AI


AstraZeneca and Neurimmune to develop and commercialise NI006
Biotech | January 07, 2022

AstraZeneca and Neurimmune to develop and commercialise NI006

Investigational human monoclonal antibody in Phase Ib development for the treatment of transthyretin amyloid cardiomyopathy, a systemic, progressive and fatal condition


Dassault Systèmes to showcase the Virtual Twin Experience of the human body at CES 2022
Digitisation | January 04, 2022

Dassault Systèmes to showcase the Virtual Twin Experience of the human body at CES 2022

The virtual world makes it possible to visualize, test, understand and predict what cannot be seen, before a patient is treated


Kyverna Therapeutics announces licence agreement with NIH
Biotech | January 04, 2022

Kyverna Therapeutics announces licence agreement with NIH

This next-generation CAR T construct was designed to improve the tolerability profile of conventional CD19 CAR Ts and developed in the laboratory of James N. Kochenderfer, M.D., at the National Cancer Institute, part of the NIH, the same laboratory that discovered axicabtagene ciloleucel